Omega Fund Management as of Sept. 30, 2017
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 11 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals | 36.9 | $65M | 2.6M | 25.10 | |
| Juno Therapeutics | 27.3 | $48M | 1.1M | 44.86 | |
| Fibrogen (FGEN) | 9.6 | $17M | 314k | 53.80 | |
| Sienna Biopharmaceuticals (SNNAQ) | 9.6 | $17M | 759k | 22.25 | |
| Jounce Therapeutics | 5.1 | $9.0M | 580k | 15.58 | |
| Pieris Pharmaceuticals (PIRS) | 3.9 | $6.9M | 1.2M | 5.76 | |
| Cymabay Therapeutics | 2.5 | $4.4M | 552k | 8.06 | |
| Egalet | 2.1 | $3.7M | 2.9M | 1.28 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 2.0 | $3.6M | 445k | 8.10 | |
| Dicerna Pharmaceuticals | 0.7 | $1.3M | 224k | 5.75 | |
| Essa Pharma | 0.3 | $492k | 1.7M | 0.29 |
